Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice

Transplant International

Volumn 29, Issue 2, 2016, Pages 241-252

  Naik, Abhijit S ^a   Dharnidharka, Vikas R ^b   Schnitzler, Mark A ^c   Brennan, Daniel C ^b   Segev, Dorry L ^d   Axelrod, David ^e   Xiao, Huiling ^c   Kucirka, Lauren ^d   Chen, Jiajing ^f   Lentine, Krista L ^c,g  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SAINT LOUIS UNIVERSITY   (United States)

Author keywords

economics; infections; kidney transplantation; medicare; registries

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DIABETIC NEPHROPATHY; FEMALE; GENDER; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH ECONOMICS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; RISK FACTOR; SEPSIS; UNITED STATES; URINARY TRACT INFECTION; ADOLESCENT; ADVERSE EFFECTS; AGED; ECONOMICS; HEALTH CARE COST; MIDDLE AGED; URINARY TRACT INFECTIONS;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH EXPENDITURES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA; SEPSIS; URINARY TRACT INFECTIONS;

EID: 84956585440     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12711     Document Type: Article

References (47)

1. Nankivell BJ, Alexander SI,. Rejection of the kidney allograft. N Engl J Med 2010; 363: 1451.
2. Lentine KL, Gheorghian A, Axelrod D, Kalsekar A, L'Italien G, Schnitzler MA,. The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation 2012; 94: 369.
3. Lodhi SA, Lamb KE, Meier-Kriesche HU,. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 2011; 11: 1226.
4. Matas AJ, Smith JM, Skeans MA, et al,. OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant 2015; 15 (Suppl 2): 1.
5. Lentine KL, Hurst FP, Jindal RM, et al,. Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis 2010; 55: 152.
6. Horwedel TA, Bowman LJ, Saab G, Brennan DC,. Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney transplant. Transpl Infect Dis 2014; 16: 261.
7. U.S. Renal Data System (USRDS). Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Altas of ESRD, Transplantation, Figure 7.30, 2010. Available at: http://www.usrds.org/2010/pdf/V2-07.pdf Accessed September 1, 2015.
8. Alangaden GJ, Thyagarajan R, Gruber SA, et al,. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant 2006; 20: 401.
9. Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand M,. Infectious complications after kidney transplantation: a single-center experience. Transpl Infect Dis 2007; 9: 302.
10. Abbott KC, Oliver JD III, Hypolite I, et al,. Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol 2001; 21: 120.
11. Tveit DJ, Hypolite IO, Poropatich RK, et al,. Hospitalizations for bacterial pneumonia after renal transplantation in the United States. J Nephrol 2002; 15: 255.
12. Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG, Kremers WK, Razonable RR,. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant 2014; 28: 683.
13. Fiorante S, Fernandez-Ruiz M, Lopez-Medrano F, et al,. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant 2011; 26: 1065.
14. Papasotiriou M, Savvidaki E, Kalliakmani P, et al,. Predisposing factors to the development of urinary tract infections in renal transplant recipients and the impact on the long-term graft function. Ren Fail 2011; 33: 405.
15. Green H, Rahamimov R, Gafter U, Leibovitci L, Paul M,. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis 2011; 13: 441.
16. Abbott KC, Swanson SJ, Richter ER, et al,. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004; 44: 353.
17. Schnitzler MA, Skeans MA, Axelrod DA, et al,. OPTN/SRTR 2013 Annual Data Report: economics. Am J Transplant 2015; 15 (Suppl 2): 1.
18. Kutinova A, Woodward RS, Ricci JF, Brennan DC,. The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006; 6: 129.
19. Whiting JF, Woodward RS, Zavala EY, et al,. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments.[see comment]. Transplantation 2000; 70: 755.
20. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ,. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
21. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905.
22. Lentine KL, Axelrod D, Klein C, et al,. Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation 2014; 98: 54.
23. Bureau of Labor Statistics. Consumer Price Index Databases. Available at: http://www.bls.gov/cpi/data.htm. Accessed May 15, 2015.
24. Glanton CW, Kao TC, Cruess D, Agodoa LY, Abbott KC,. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003; 63: 647.
25. Lentine KL, Xiao H, Brennan DC, et al,. The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J 2009; 158: 972.
26. Salvalaggio PR, Dzebisashvili N, Pinsky B, et al,. Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care 2009; 32: 600.
27. Gheorghian A, Schnitzler MA, Axelrod DA, Kalsekar A, L'Italien G, Lentine KL,. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation 2012; 94: 241.
28. Schnitzler MA, Johnston K, Axelrod D, Gheorghian A, Lentine KL,. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011; 91: 1347.
29. Lamb KE, Lodhi S, Meier-Kriesche HU,. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011; 11: 450.
30. United States Renal Data System. Chapter 6:Transplantation. Available at: http://www.usrds.org/2014/download/V2-Ch-06-Transplantation-14.pdf. Accessed May 15, 2015. 2014.
31. Kosmadakis G, Daikos GL, Pavlopoulou ID, et al,. Infectious complications in the first year post renal transplantation. Transpl Proc 2013; 45: 1579.
32. Dharnidharka VR, Agodoa LY, Abbott KC,. Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients-an analysis of USRDS data. Am J Transplant 2007; 7: 653.
33. Wilson CH, Rix DA, Manas DM,. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2013; 6: CD004925.
34. Sadeghi M, Daniel V, Naujokat C, Wiesel M, Hergesell O, Opelz G,. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection. Transpl Int 2005; 18: 177.
35. Ciszek M, Paczek L, Bartlomiejczyk I, Mucha K,. Urine cytokines profile in renal transplant patients with asymptomatic bacteriuria. Transplantation 2006; 81: 1653.
36. Groth CG, Backman L, Morales JM, et al,. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999; 67: 1036.
37. Ekberg H, Tedesco-Silva H, Demirbas A, et al,. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
38. Flechner SM, Glyda M, Cockfield S, et al,. The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. Am J Transplant 2011; 11: 1633.
39. Guerra G, Ciancio G, Gaynor JJ, et al,. Randomized trial of immunosuppressive regimens in renal transplantation. J Am Soc Nephrol 2011; 22: 1758.
40. Dharnidharka VR, Araya CE, Wadsworth CS, McKinney MC, Howard RJ,. Assessing the value of ureteral stent placement in pediatric kidney transplant recipients. Transplantation 2008; 85: 986.
41. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 (Suppl. 3): S1.
42. Tanriover B, Wright SE, Foster SV, et al,. High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis. Transpl Proc 2008; 40: 3393.
43. Orandi BJ, Chow EH, Hsu A, et al,. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant 2015; 15: 489.
44. Israni AK, Salkowski N, Gustafson S, et al,. New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. J Am Soc Nephrol 2014; 25: 1842.
45. Lentine KL, Rocca Rey LA, Kolli S, et al,. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol 2008; 3: 1090.
46. Lentine KL, Brennan DC, Schnitzler MA,. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496.
47. Woodward RS, Schnitzler MA, Baty J, et al,. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3: 590.